Near-Infrared Light Therapy Combined With Lecanemab for Mild Alzheimer's Disease
Near-Infrared Light Therapy Combined With Lecanemab for Mild Alzheimer's Disease
Recruiting · NCT06992804 · Registry updated 2025-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Near-Infrared Light Therapy Combined With Lecanemab for Mild Alzheimer's Disease | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Early phase 1 | 2025-09-09 | NCT06992804 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Xuanwu Hospital, Beijing | 232 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Xuanwu Hospital, Capital Medical University | Beijing | China | 38 |